362
I. Ibrahem et al. / Tetrahedron 62 (2006) 357–364
column chromatography (EtOAc/pentane 1:10) to afford
a-aminomethylated ketone 3. The ee of the ketones was
determined by chiral-phase HPLC analysis (Daicel Chiral-
pak AD column, lZ244 nm, v 0.5 mL/min, hex/i-PrOH).
CDCl3) d (ppm): 25.1, 28.0, 32.3, 42.5, 45.6, 50.0, 56.1,
114.9, 115.2, 142.2, 152.6, 213.6; HPLC (Daicel Chiralpak
AD, hexanes/i-PrOH 98:2, flow rate 0.5 mL/min, lZ
254 nm): major isomer: tRZ25.40 min; minor isomer:
tRZ26.98 min; [a]2D5C6.1 (c 1.1, CHCl3).
3.2.1. (2S)-(4-Methoxyphenylamino-methyl)-cyclohexa-
none 3a. Yellow solid (219 mg), 94% 1H NMR
(400 MHz, CDCl3) d (ppm): 1.49 (m, 1H, CH [Cy]), 1.67
(m, 2H, CH2 [Cy]), 1.90 (m, 1H, CH [Cy]), 2.10 (m, 2H,
CH2 [Cy]), 2.35 (m, 2H, CH2 [Cy]), 2.65 (m, 1H, CHC]O),
3.05 (dd, JZ13.3, 4.7 Hz, 1H, CHHN), 3.37 (dd, JZ13.3,
7.8 Hz, 1H, CHHN), 3.74 (s, 3H, OCH3), 6.59 (m, 2H,
ArH), 6.77 (m, 2H, ArH); 13C NMR (100 MHz, CDCl3) d
(ppm): 25.1, 28.0, 32.3, 42.5, 45.6, 50.0, 56.1, 114.9, 115.2,
142.2, 152.6, 213.6; HPLC (Daicel Chiralpak AD, hexanes/
i-PrOH 96:4, flow rate 0.5 mL/min, lZ254 nm): major
isomer: tRZ44.31 min; minor isomer: tRZ58.79 min;
[a]2D5C4.6 (c 2, CHCl3); MALDI-TOF MS: 256.1008;
C14H19NO2 (MCNaC: calcd 256.1313).
1
3.2.6. Compound 3f. Yellow oil, 219 mg, 94% H NMR
(400 MHz, CDCl3) d (ppm): 2.16 (s, 3H, CH3C]O), 2.27
(m, 1H, CHCH]CH2), 2.47 (m, 1H, CHCH]CH2), 3.93
(m, 1H, CHCH2), 3.20 (dd, JZ12.8, 4.8 Hz, 1H, CHHN),
3.35 (dd, JZ12.9, 8.3 Hz, 1H, CHHN), 3.74 (s, 3H, OCH3),
5.10 (m, 2H, CH2]CH), 5.75 (m, 1H, CH2]CH), 6.57 (d,
JZ8.9 Hz, 2H, ArH), 6.77 (d, JZ8.9 Hz, 2H, ArH); 13C
NMR (100 MHz, CDCl3) d (ppm): 30.1, 34.1, 45.8, 51.8,
56.0, 114.7, 115.2, 117.8, 135.0, 142.0, 152.7, 211.3; HPLC
(Daicel Chiralpak AD, hexanes/i-PrOH 98:2, flow rate
0.5 mL/min, lZ254 nm): major isomer: tRZ43.40 min;
minor isomer: tRZ47.20 min; [a]2D5C3.6 (c 2.5, CHCl3).
1
3.2.7. Compound 3g. Yellow oil (220 mg, 72%) H NMR
3.2.2. Compound (2S)-3b. 248 mg, 85% 1H NMR
(400 MHz, CDCl3) white solid d (ppm): 1.99 (m, 2H, CH2
[Cy]), 2.08 (m, 2H, CH2 [Cy]), 2.38 (m, 1H, CH [Cy]), 2.65
(m, 1H, CH [Cy]), 2.95 (m, CH, [Cy]), 3.10 (dd, JZ13.2,
4.7 Hz, 1H, CHHN), 3.33 (dd, JZ13.2, 7.3 Hz, 1H,
CHHN), 3.73 (s, 3H, OCH3), 4.00 (m, 4H, 2!OCH2),
6.56 (m, 2H, ArH), 6.77 (m, 2H, ArH); 13C NMR
(100 MHz, CDCl3) d (ppm): 34.4, 38.4, 38.7, 44.8, 45.9,
55.7, 64.6, 107.2, 142.1, 152.2, 211.8; HPLC (Daicel
Chiralpak AD, hexanes/i-PrOH 98:2, flow rate 0.5 mL/min,
lZ254 nm): major isomer: tRZ148.04 min; minor isomer:
tRZ160.40 min; [a]2D5K2.0 (c 1.0, CHCl3).
(400 MHz, CDCl3) d (ppm): 0.88 (t, JZ6.7 Hz, 3H), 1.28
(m, 12H), 2.15 (s, 3H), 2.82 (m, 1H), 3.17 (dd, JZ12.8,
4.6 Hz, 1H), 3.32 (dd, JZ12.9, 8.6 Hz, 1H), 3.73 (s, 3H),
6.56 (d, JZ8.9 Hz, 2H), 6.77 (d, JZ9.1 Hz, 2H); 13C NMR
(100 MHz, CDCl3) d (ppm): 14.2, 22.8, 27.5, 29.2, 29.8,
29.9, 32.0, 46.2, 52.6, 114.5, 115.1, 120.0, 142.2, 152.5,
212.3; HPLC (Daicel Chiralpak AD, hexanes/i-PrOH 99:1,
flow rate 0.5 mL/min, lZ254 nm): major isomer: tRZ
41.50 min; minor isomer: tRZ43.10 min; [a]2D5C2.0 (c 1.4,
CHCl3).
1
3.2.8. Compound 3h. Yellow oil (126 mg, 60%) H NMR
(400 MHz, CDCl3) d (ppm): 2.17 (s, 3H, CH3), 3.76 (s, 3H,
OMe), 4.56 (dd, JZ5.5, 7.8 Hz, 1H, CHOH), 4.86 (d, JZ
2.5 Hz, 1H, CH2NHAr), 5.04 (d, JZ2.5 Hz, 1H, CH2-
NHAr), 6.60 (d, JZ9.0 Hz, 2H), 6.85 (d, JZ9.0 Hz, 2H);
13C NMR (100 MHz, CDCl3) d (ppm): 26.5, 50.6, 55.9,
83.7, 114.9, 115.8, 140.4, 153.6, 209.5; HPLC (Daicel
Chiralpak AD, hexanes/i-PrOH 90:10, flow rate 0.5 mL/
min, lZ254 nm): major isomer: tRZ18.97 min; minor
isomer: tRZ23.53 min; [a]2D5K9.4 (c 1, CHCl3).
3.2.3. Compound (2S)-3c. 223 mg, 84% 1H NMR
(400 MHz, CDCl3) yellowish oil d (ppm): 1.44 (s, 3H,
Me), 1.96 (s, 3H, Me), 3.29 (m, 1H), 3.37 (m, 1H), 3.73 (s,
3H, OMe), 4.0 (d, JZ17.8 Hz, 1H), 4.27 (d, JZ17.8 Hz,
1H), 4.43 (m, 1H), 6.65 (d, JZ8.9 Hz, 2H, ArH), 6.78 (d,
JZ8.9 Hz, 2H, ArH); 13C NMR (100 MHz, CDCl3) d
(ppm): 23.8, 24.2, 44.5, 55.8, 66.8, 73.4, 101.1, 115.0,
115.4, 141.7, 152.9, 208.9; (Daicel Chiralpak AD, hexanes/
i-PrOH 98:2, flow rate 0.5 mL/min, lZ254 nm): major
isomer: tRZ44.63 min; minor isomer: tRZ54.14 min;
[a]2D5K129.3 (c 2.5, CHCl3).
3.2.9. Compound 3i. Yellow solid (148 mg, 45%) 1H NMR
(400 MHz, CDCl3) d (ppm): 1.49 (m, 1H, CH [Cy]), 1.67
(m, 2H, CH2 [Cy]), 1.90 (m, 1H, CH [Cy]), 2.10 (m, 2H,
CH2 [Cy]), 2.35 (m, 2H, CH2 [Cy]), 2.65 (m, 1H, CHC]O),
3.07 (dd, JZ13.3, 4.5 Hz, 1H, CH2NHAr), 3.37 (dd, JZ
13.6, 7.8 Hz, 1H, CH2NHAr), 6.36 (d, JZ8.8 Hz, 2H, ArH),
7.39 (d, JZ8.8 Hz, 2H, ArH); 13C NMR (100 MHz, CDCl3)
d (ppm): 25.1, 28.0, 32.2, 42.5, 44.0, 49.9, 115.4, 117.4,
138.0, 147.8, 213.3; HPLC (Daicel Chiralpak AD, hexanes/
i-PrOH 98:2, flow rate 0.5 mL/min, lZ254 nm): major
isomer: tRZ53.80 min; minor isomer: tRZ78.80 min;
[a]2D5C2.2 (c 1.1, CHCl3).
3.2.4. Compound trans-(2S)-3d. (3dC3d0, 210.2 mg,
85%) yellow solid, major diastereomer: 1H NMR
(400 MHz, CDCl3) d (ppm): 1.0 (d, JZ6.3 Hz, 3H,
CHCH3), 1.29 (m, 1H, CH [Cy]), 1.71 (m, 2H, CH2 [Cy]),
2.01 (m, 2H, CH2 [Cy]), 2.35 (m, 2H, CH2 [Cy]), 2.7 (m,
1H, CH [Cy]), 3.05 (m, H, CHHN), 3.35 (m, 1H, CHHN),
3.73 (s, 3H, OCH3), 6.56 (m, 2H, ArH), 6.77 (m, 2H, ArH);
13C NMR (100 MHz, CDCl3) d (ppm): 21.2, 31.7, 35.6,
40.2, 41.6, 45.0, 48.6, 55.7, 114.4, 114.9, 142.2, 152.1,
213.4; HPLC (Daicel Chiralpak AD, hexanes/i-PrOH 96:4,
flow rate 0.5 mL/min, lZ254 nm): major isomer: tRZ
48.8 min; minor isomer: tRZ52.9 min.
3.2.10. Compound 3j. Yellow solid (200 mg, 71%) 1H
NMR (400 MHz, CDCl3) d (ppm): 1.49 (m, 1H, CH [Cy]),
1.67 (m, 2H, CH2 [Cy]), 1.90 (m, 1H, CH [Cy]), 2.10 (m,
2H, CH2 [Cy]), 2.35 (m, 2H, CH2 [Cy]), 2.65 (m, 1H,
CHC]O), 3.07 (dd, JZ13.3, 4.5 Hz, 1H, CH2NHAr), 3.37
(dd, JZ13.4, 7.7 Hz, 1H, CH2NHAr), 6.45 (d, JZ8.9 Hz,
2H, ArH), 7.21 (d, JZ8.9 Hz, 2H, ArH); 13C NMR
(100 MHz, CDCl3) d (ppm): 25.1, 27.9, 32.2, 42.4, 44.1,
1
3.2.5. Compound 3e. Yellow oil 211 mg, 80% H NMR
(400 MHz, CDCl3) d (ppm): 0.80 (m, 3H), 1.30 (m, 8H),
2.15 (s, 3H), 2.82 (m, 1H), 3.17 (dd, JZ12.8, 4.7 Hz, 1H),
3.32 (dd, JZ12.8, 8.6 Hz, 1H), 3.73 (s, 3H), 6.56 (d, JZ
9.1 Hz, 2H), 7.26 (d, JZ9.1 Hz, 2H); 13C NMR (100 MHz,